Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 352 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase1, Phase2, Recruiting

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

for
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms,
Location: Norfolk VA, Fairfax VA, Miami Beach FL,
Sponsor: Corcept Therapeutics

Sex: Female

Age: 18+

Code: NCT06906341

Phase2, Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Columbus OH, Grand Rapids MI, Houston TX,
Sponsor: Tanabe Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT06943521

Phase1, Phase2, Recruiting

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

for
Breast Cancer, Breast Cancer Metastatic,
Location: Boston MA, Durham NC, Buffalo NY, Orlando FL,
Sponsor: Incyclix Bio

Sex: All

Age: 18+

Code: NCT05735080

Phase1, Phase2, Recruiting

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

for
Ovarian Cancer
Location: Maywood IL
Sponsor: Loyola University

Sex: All

Age: 18+

Code: NCT05983276

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

for
Clinical Stage IV Gastric Cancer AJCC v8,
Location: Greenlawn NY, Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT04329494

Phase1, Recruiting

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

for
Ovarian Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Female

Age: 18+

Code: NCT05316129

Phase1, Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

for
Ovarian Cancer, Cholangiocarcinoma Recurrent,
Location: Philadelphia PA, Tampa FL, Madison WI, Houston TX
Sponsor: Verismo Therapeutics

Sex: All

Age: 18+

Code: NCT05568680

Phase1, Recruiting
New

Uterine Lavage to Detect Ovarian Cancer Risk

for
BRCA Hereditary Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Female

Age: 18+

Code: NCT07772869

Recruiting

Combination Therapy in Cancers With Mutations in DNA Repair Genes

for
Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05694715

Phase1, Recruiting

Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes

for
Genetic Testing, BRCA1/2
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 25+

Code: NCT03396341

Recruiting

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

for
Ovary Cancer, Endometrial Cancer, Uterine Cancer,
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 60+

Code: NCT05743517

Recruiting

Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

for
Familial Cancer, BRCA1-Associated Protein-1 (BAP1) Mutations,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 30 - 70+

Code: NCT04431024

Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma,
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT04851119

Phase1, Phase2, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Hackensack NJ, Montreal, Toronto, Vancouver,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06476808

Phase1, Recruiting

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

for
Ovary Cancer, Fallopian Tube Cancer,
Location: Philadelphia PA, Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female

Age: 18+

Code: NCT06617923

Phase2, Recruiting

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

for
Ovarian Neoplasms, Endometrial Neoplasms,
Location: Mineola NY, New York NY, Columbus OH, Grand Rapids MI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06400472

Phase1, Recruiting

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

for
Ovarian High Grade Serous Adenocarcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT05998135

Phase2, Recruiting

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

for
Platinum-Resistant Ovarian Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Female

Age: 18+

Code: NCT05225363

Phase1, Recruiting

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

for
Ovarian Clear Cell Adenocarcinoma,
Location: Buffalo NY, Houston TX
Sponsor: Roswell Park Cancer Institute

Sex: Female

Age: 18+

Code: NCT05231122

Phase2, Recruiting